Who is it for?
Renal mass biopsy determines whether a kidney mass is benign or malignant and, if malignant, its type. It is increasingly used — particularly for small renal masses — to choose correctly between surveillance, ablation and surgery. Ultrasound-guided parenchymal (medical) kidney biopsy is also performed to diagnose medical kidney disease — unexplained kidney dysfunction, significant protein leakage or urinary abnormalities — usually at the request of the nephrology team.
Not every mass needs a biopsy; some imaging findings are typical enough. The decision is made with the urology team, based on the mass and the treatment plan.
How it is done — step by step
Planning
The shortest, safest track is planned with ultrasound (CT when needed); you usually lie prone or on your side.
Local anaesthesia
The skin and needle track are numbed.
Sampling
A core needle takes several samples under image guidance; each pass lasts seconds.
Compression and observation
Pressure is applied and you are observed on bed rest for a few hours.
What to expect on the day
You will be asked to fast; blood thinners are adjusted in advance.
The procedure takes minutes, followed by a few hours of observation. The first urinations may be slightly pink — usually self-limiting. Most patients go home the same day.
Risks and Limitations
The most common findings are transient blood in the urine and a small self-resolving collection around the kidney. Bleeding requiring intervention is rare; very rarely, vessel injury may need additional treatment. The observation period exists for these possibilities.
A limit: the sample may occasionally be non-diagnostic or not represent the whole mass; in that case repeat biopsy or a direct treatment decision is made together with urology.
Recovery and follow-up
Avoid heavy lifting and strenuous exercise for 24–48 hours; then return to normal life.
Pathology is ready within days to one or two weeks. The roadmap — active surveillance, ablation or surgery — is drawn together with you and the urology team.
Scientific References
- CIRSE — Perkütan İğne Biyopsisi Kılavuzu (Veltri A ve ark., Cardiovasc Intervent Radiol, 2017)
- AUA — Küçük böbrek kitleleri kılavuzu (Campbell SC ve ark., J Urol, 2021)
- SIR — Perkütan iğne biyopsisi kalite iyileştirme kılavuzu (Gupta S ve ark., J Vasc Interv Radiol, 2010)
Frequently Asked Questions
Does every kidney mass need a biopsy?
No. When imaging is typical, decisions can be made without one. Biopsy is planned when the result would change treatment.
Is blood in my urine normal?
Slight pink discoloration of the first urinations can occur and usually settles by itself. Contact us for visible or persistent bleeding.
Will it harm my kidney?
Sampling with a thin needle is not expected to affect kidney function permanently; the track is planned under image guidance, avoiding vessels.
Can biopsy spread the cancer?
Needle-tract seeding is very rarely reported in renal mass biopsy; with modern technique the risk is extremely low and clearly outweighed by the benefit of an accurate diagnosis.
When is the result ready?
Usually within days to one or two weeks, reviewed together with your urology team.
Can I go home the same day?
Usually yes — after a few hours of observation.
The information on this page is for general education; diagnosis and treatment decisions are made individually after clinical evaluation.